DGX
Quest Diagnostics IncorporatedNYSEHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$21.85B
P/E Ratio
22.48
EPS
$8.74
Beta
0.63
52W High
$213.50
52W Low
$155.09
50-Day MA
$195.42
200-Day MA
$183.46
Dividend Yield
1.63%
Profit Margin
8.99%
Forward P/E
18.38
PEG Ratio
1.56
About Quest Diagnostics Incorporated
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Fundamentals
| Revenue (TTM) | $11.04B |
| Gross Profit (TTM) | $3.68B |
| EBITDA | $2.17B |
| Operating Margin | 14.00% |
| Return on Equity | 14.70% |
| Return on Assets | 6.20% |
| Revenue/Share (TTM) | $99.41 |
| Book Value | $65.18 |
| Price-to-Book | 2.99 |
| Price-to-Sales (TTM) | 1.98 |
| EV/Revenue | 2.503 |
| EV/EBITDA | 12.76 |
| Quarterly Earnings Growth (YoY) | 11.00% |
| Quarterly Revenue Growth (YoY) | 7.10% |
| Shares Outstanding | $109.87M |
| Float | $109.26M |
| % Insiders | 0.41% |
| % Institutions | 100.06% |
Historical Volatility
HV 10-Day
10.33%
HV 20-Day
15.69%
HV 30-Day
17.17%
HV 60-Day
25.82%
HV Rank
11.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($218.50 target)
2
Strong Buy7
Buy7
Hold1
Strong SellData last updated: 3/26/2026